American Renal Associates Holdings, Inc. Announces Withdrawal of Secondary Public Offering of Common Stock
March 28 2018 - 6:01PM
Business Wire
American Renal Associates Holdings, Inc. (NYSE: ARA) (“ARA” or
the “Company”), a provider of outpatient dialysis services, today
announced that it has withdrawn the offering of shares of its
common stock that was announced on Monday, March 26, 2018. The
Company believes that current market conditions are not conducive
for an offering on terms that would be in the best interests of its
stockholders.
This press release shall not constitute an offer to sell or a
solicitation of an offer to buy, nor shall there be any sale of,
these securities in any state or jurisdiction in which such an
offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of such state or
jurisdiction.
About American Renal Associates
American Renal Associates Holdings, Inc. (NYSE: ARA) is a
provider of outpatient dialysis services in the United States. As
of December 31, 2017, ARA operated 228 dialysis clinic locations in
26 states and the District of Columbia serving approximately 15,600
patients with end stage renal disease. ARA operates principally
through a physician partnership model, in which it partners with
approximately 400 local nephrologists to develop, own and operate
dialysis clinics.
Forward-Looking Statements
This press release contains “forward-looking statements” within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. All forward-looking statements included in this release
are based upon information available to the Company as of the date
of this release, which may change, and the Company assumes no
obligation to update any such forward-looking statements. These
statements are not guarantees of future performance and actual
results could differ materially from the Company’s current
expectations. Factors that could cause or contribute to such
differences include those risks and uncertainties described in
“Risk Factors” and “Special Note Regarding Forward-Looking
Statements” in our Annual Report on Form 10-K for the year ended
December 31, 2017. The Company assumes no obligation and does not
intend to update the forward-looking statements provided, whether
as a result of new information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180328006203/en/
American Renal Associates Holdings, Inc.Darren Lehrich,
978-522-6063SVP Strategy & Investor
Relationsdlehrich@americanrenal.com
American Renal Associates (NYSE:ARA)
Historical Stock Chart
From Aug 2024 to Sep 2024
American Renal Associates (NYSE:ARA)
Historical Stock Chart
From Sep 2023 to Sep 2024